Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H27NO3 |
| Molecular Weight | 341.444 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN(CC)CCOC(=O)C(O)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=PYPJRLVCFAVWFR-UHFFFAOYSA-N
InChI=1S/C21H27NO3/c1-3-15-22(4-2)16-17-25-20(23)21(24,18-11-7-5-8-12-18)19-13-9-6-10-14-19/h5-14,24H,3-4,15-17H2,1-2H3
| Molecular Formula | C21H27NO3 |
| Molecular Weight | 341.444 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Benapryzine is a dialkylaminoethanol ester of diphenylacetic acid. It is a muscarinic cholinoceptor antagonist with negligible peripheral effects. Benapryzine in addition to its anti-acetylcholine action antagonizes both maximal electroshock and metrazol-induced convulsions in mice. This feature is not generally shown by anti-acetylcholine agents but is seen with orphenadrine. Side effects of benapryzine were rare. They are: drowsiness, dry mouth, confusion, disorientation, hallucinations and postural syncope with measurable postural hypotension. Benapryzine has been used as an antiparkinsonian agent.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4581246
30-45 mg daily
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:49:35 GMT 2025
by
admin
on
Mon Mar 31 18:49:35 GMT 2025
|
| Record UNII |
14FPC4V3AX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00865055
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
14FPC4V3AX
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
18551
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
C78798
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
3135
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
22487-42-9
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110766
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
100000086590
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
SUB05698MIG
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | |||
|
m66
Created by
admin on Mon Mar 31 18:49:35 GMT 2025 , Edited by admin on Mon Mar 31 18:49:35 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |